Characterization of Tumor Microenvironment in Lung Adenocarcinoma Identifies Immune Signatures to Predict Clinical Outcomes and Therapeutic Responses

BACKGROUND AND OBJECTIVE: Increasing evidence has elucidated the clinicopathological significance of individual TME component in predicting outcomes and immunotherapeutic efficacy in lung adenocarcinoma (LUAD). Therefore, we aimed to investigate whether comprehensive TME-based signatures could predi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Donglai, Wang, Yifei, Zhang, Xi, Ding, Qifeng, Wang, Xiaofan, Xue, Yuhang, Wang, Wei, Mao, Yiming, Chen, Chang, Chen, Yongbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973234/
https://www.ncbi.nlm.nih.gov/pubmed/33747907
http://dx.doi.org/10.3389/fonc.2021.581030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973234/
https://www.ncbi.nlm.nih.gov/pubmed/33747907
http://dx.doi.org/10.3389/fonc.2021.581030

Ejemplares similares